Showing 421-430 of 10031 results for "".
DermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.Incorporating Cosmetic Dermatology into Your Medical Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/incorporating-cosmetic-dermatology-into-your-medical-practice/18763/Cosmetic Dermatology experts Gary D. Monheit, MD, Nancy J. Samolitis, MD, and Joel L. Cohen, MD share tips for adding aesthetic offerings to an established medical dermatology practice or for young physicians opening a new practice. Sitting down with host Neal Bhatia, MD, they all emphasize the impoWhat’s Growing in Pattern Hair Loss Care?
https://practicaldermatology.com/topics/hair-nails/whats-growing-in-pattern-hair-loss-care/23934/Peter Panagotacos, MD, provides expert advice for surgical and nonsurgical options for treating androgenetic alopecia.SCALE 2024: Listen as Dr. Joel Cohen and Dr. Suneel Chilukuri on Microwave Therapy
https://practicaldermatology.com/error/404/Suneel Chilukuri, MD, discusses the various applications of microwave therapy, including non-melanoma skin cancer, with Joel Cohen, MD, at Music City SCALE.Flappers: 2020 Edition
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/flappers-2020-edition/19735/Flaps can be intimidating, but with planning and skillful execution, they can be quite effective. Andrew Kaufman, MD discusses technique with host Joel L. Cohen, MD."Human Sigma" and the Aesthetic Practice
https://practicaldermatology.com/topics/practice-management/-human-sigma-and-the-aesthetic-practice/19212/Edwin Williams, MD, FACS discusses how "Human Sigma" has influenced his practice and improved practice efficiency.What to Know About Sunscreens and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/what-to-know-about-sunscreens-and-more/19888/Henry Lim, MD summarizes a presentation from San Diego Dermatology Symposium, offering updates on sunscreen labeling and more.Multi-Use Devices: Recommendations for Assessment and Selection
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/multi-use-devices-recommendations-for-assessment-and-selection/19214/Jason Pozner, MD offers insights on the selection and use of multi-use devices in practice.Analyzing the Overlap Between Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/analyzing-the-overlap-between-atopic-dermatitis-prurigo-nodularis-and-chronic-spontaneous-urticaria/50877/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, is joined by Editorial Board member Jason E. Hawkes, MD, MS, FAAD, to discuss three different immune-mediated inflammatory skin conditions and how understanding their mechanisms can inform optimal treatment, based on the InternationalDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)